HB 8587 — AN ACT RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES
Last action — 06/02/2026 Committee recommended measure be held for further study
-
✓Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill is in committee in the House. Introduced May 27, 2026. It must pass committee before a floor vote.
Next likely step: a committee vote, then a floor vote in the House.
Odds of enactment
Low chanceBased on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.
Upgrade to see the exact probability and what's driving it.
A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.
Prognosis
-
In Committee
Current position in the legislative process.
-
4 sponsors
4 primary, 0 co-sponsors signed on.
-
Single-party support
Sponsorship is currently within one party (4 D).
Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.
In plain language
Requires health insurance to cover certain treatments for menopause symptoms.
The bill mandates that health insurance policies provide coverage for medically necessary treatments for peri-menopause and menopause symptoms, as long as they are recommended by licensed healthcare providers in Rhode Island. This includes both hormonal and non-hormonal therapies deemed safe and effective.
What this means for you
- Consumers: Individuals experiencing menopause symptoms may have better access to covered treatment options.
- Healthcare: Healthcare providers will have the authority to prescribe necessary therapies with insurance support.
Summary
Mandates health insurance coverage for medically necessary hormonal/non-hormonal therapy to treat symptoms of peri-menopause/menopause, if therapy is recommended by qualified healthcare provider licensed in RI and has proven safe and effective.
Bill Text
- 8587 View text Current pdf
Action History
-
06/02/2026 Committee recommended measure be held for further study
-
05/29/2026 Scheduled for hearing and/or consideration (06/02/2026)
-
05/27/2026 Introduced, referred to House Health & Human Services
Sponsors
- Kathleen A. Fogarty · Primary
- Julie A. Casimiro · Primary
- Jenni A. Furtado · Primary
- Karen Alzate · Primary
Sponsorship breakdown
Export CSV (upgrade) →4 sponsors · 0 co-sponsors · 110 not signed on
Sponsors (4)
- Kathleen A. Fogarty Democratic
- Julie A. Casimiro Democratic
- Jenni A. Furtado Democratic
- Karen Alzate Democratic
Co-sponsors (0)
None.
Not signed on (110)
110 members have not signed on to this bill.
Show all 110 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 8587 do?
- Mandates health insurance coverage for medically necessary hormonal/non-hormonal therapy to treat symptoms of peri-menopause/menopause, if therapy is recommended by qualified healthcare provider licensed in RI and has proven safe and effective.
- Who sponsors HB 8587?
- HB 8587 is sponsored by Kathleen A. Fogarty (Democratic), Julie A. Casimiro (Democratic), Jenni A. Furtado (Democratic), and Karen Alzate (Democratic).
- What is the current status of HB 8587?
- This bill is in committee in the House. Introduced May 27, 2026. It must pass committee before a floor vote.
- Where can I track HB 8587?
- Track HB 8587 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 8587
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 8587
Last checked for changes about 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →